Fig. 1 · Structure

Documents & Downloads

7ACC1

Cat. No. A15810 CAS 50995-74-9

MCT Inhibitor

7ACC1 selectively interfere with lactate fluxes in the lactate-rich tumor microenvironment; inhibits lactate influx but not efflux in tumor cells expressing MCT1 and MCT4 transporters.

In Stock

Publications for 7ACC1

1 publication citing this product

  1. Daniel Gundel, .et al. , Int J Mol Sci, 2021, Feb; 22(4): 1645 PMID: 33562048

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
4T1 IC50 > 100 μM Antiproliferative activity against mouse 4T1 cells assessed as inhibition of cell proliferation by MTT assay [PMID: 34626786]
HepG2 IC50 > 100 μM Antiproliferative activity against human HepG2 cells after 48 hrs by MTT assay [PMID: 28666736]
MCF-10A IC50 > 100 μM Cytotoxicity against human MCF-10A cells assessed as inhibition of cell proliferation by MTT assay [PMID: 34626786]
MCF7 IC50 > 100 μM Antiproliferative activity against human MCF7 cells after 48 hrs by MTT assay [PMID: 28666736]
MDA-MB-231 IC50 > 100 μM Antiproliferative activity against human MDA-MB-231 cells after 48 hrs by MTT assay [PMID: 28666736]
MDA-MB-231 IC50 > 100 μM Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell proliferation by MTT assay [PMID: 34626786]
SiHa IC50 0.86 μM Inhibition of MCT4-mediated [14C]-lactate uptake in human SiHa cells in lactate-containing medium assessed as remaining lactate concentration in culture medium after 24 hrs by liquid scintillation counting [PMID: 24095010]
SiHa EC50 1.8 μM Cytotoxicity against human SiHa cells in lactate-containing medium after 72 hrs by MTT assay [PMID: 24095010]
SiHa IC50 250 nM Inhibition of MCT4-mediated [14C]-lactate uptake in human SiHa cells in lactate-containing medium assessed as remaining lactate concentration in culture medium after 12 mins by liquid scintillation counting [PMID: 24095010]
SK-HEP1 IC50 > 100 μM Antiproliferative activity against human SKHEP1 cells after 48 hrs by MTT assay [PMID: 28666736]
WiDr IC50 > 100 μM Antiproliferative activity against human WiDr cells assessed as inhibition of cell proliferation by MTT assay [PMID: 34626786]

11 records · Scroll to view more

7ACC1 Research Summary

This section summarizes 1 in vitro study of 7ACC1 from 1 published reference.

7ACC1 In Vitro Studies

In a preliminary 4T1 mouse breast-cancer cell assay, 10 µM 7ACC1 reduced cell-associated [18F]FACH radioactivity from 4.7 to 1.1 %ID/mg protein after 30 minutes of tracer incubation. 7ACC1 was added 10 minutes before the tracer. The vehicle group had n = 3 (mean ± SD), whereas the 7ACC1 condition had n = 1. This single treated determination supports a limited tracer-uptake observation; it does not establish an IC50 or transporter-isoform selectivity. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Preliminary inhibition of [18F]FACH cell-associated uptake in 4T1 cells

Cell-based study · Murine 4T1 triple-negative breast-cancer cells; tracer uptake at 37 °C, pH 7.4, 5% CO2 [1]

7ACC1 pretreatment was associated with lower cell-associated tracer radioactivity than vehicle. Only one treated determination was reported, precluding a robust estimate of reproducibility. This is a cellular radiotracer endpoint, not a direct lactate transport, binding-affinity or purified-transporter assay.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Cell-associated [18F]FACH radioactivity normalized to injected dose and cellular protein after 30 minutes%ID/mg protein Vehicle: 4.7 %ID/mg protein; 10 µM 7ACC1: 1.1 %ID/mg protein. Figure 7: vehicle n = 3, mean ± SD; 7ACC1 n = 1.[1]

Literature-Reported Treatment Conditions

Treatment concentration
10 µM final 7ACC1; 200 kBq [18F]FACH per well
Exposure duration
7ACC1 added 10 min before tracer; uptake measured after a further 30 min tracer incubation
Method
Cell pretreatment followed by radiotracer uptake in serum-free RPMI 1640 with 20 mM HEPES, pH 7.4; washing, cell lysis, gamma counting and protein normalization
Vehicle
Vehicle diluted in incubation medium (1% DMSO as described in Methods 4.10); final well DMSO fraction is not unambiguously specified.
Co-treatment
[18F]FACH is the assay radiotracer, not a therapeutic combination.
Reported limits
No treated replicate variance or inferential statistic for Figure 7; no paper-specific SKU, lot, CAS or salt designation. The accessible main text supplies the uptake protocol; SI was not retrieved.
Methods and source locations

Compound reported in the paper: 7ACC1; Compound label in the paper: 7ACC1 (AdooQ Bioscience)

Applies to the reported 7ACC1 cellular tracer assay; no current Adooq lot validation, potency, isoform selectivity or animal efficacy claim.

Results §2.8; Figure 7 and caption; Methods §§4.10–4.11

Cell-associated [18F]FACH radioactivity normalized to injected dose and cellular protein after 30 minutes: Gamma counting of cell lysate; BCA protein assay relative to BSA standard. Values are stated in Results 2.8. — Results §2.8; Figure 7 and caption; Methods §§4.10–4.11

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 50995-74-9
Applications MCT Inhibitor
Formula C14H15NO4
Molecular Weight 261.27
Synonyms DEAC; Coumarin D 1421; D 1421
SMILES
CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C(=O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 45 mg/mL (172.23 mM)
Water Insoluble
Ethanol Insoluble

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

7ACC1 Research References

  1. [1] Gündel D, Sadeghzadeh M, Deuther-Conrad W, et al. Preclinical Evaluation of [18F]FACH in Healthy Mice and Piglets: An 18F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET. International Journal of Molecular Sciences (2021). PMID: 33562048 DOI: 10.3390/ijms22041645 Source material

Publications

1 publication citing this product

  1. Daniel Gundel, .et al. , Int J Mol Sci, 2021, Feb; 22(4): 1645 PMID: 33562048

Added to your cart

View Cart Checkout
Loading...